FIELD: medicine.
SUBSTANCE: invention relates to a method for the treatment of a person with acute kidney injury. The method involves intravenous administration to the patient of an effective amount of the compound of the structural formula specified below or its pharmaceutically acceptable salt.
EFFECT: decreased level of creatinine in plasma, improvement in kidney function.
15 cl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED CYANOPYRROLIDINES HAVING ACTIVITY OF USP30 INHIBITORS | 2020 |
|
RU2822680C1 |
| HYDROXYPYRIDOXAZEPINES AS Nrf2 ACTIVATORS | 2020 |
|
RU2812931C2 |
| MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2820540C2 |
| CRYSTAL AND SALT FORMS OF PPAR AGONIST COMPOUNDS | 2017 |
|
RU2759724C2 |
| AMIDE COMPOUNDS | 2015 |
|
RU2684906C2 |
| 5-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780322C2 |
| APPLYING (R)-IBUPROFEN METHANESULFONAMIDE AND ITS SALTS FOR TREATMENT AND PROPHYLAXIS OF REJECTION RESPONSE OF TRANSPLANTABLE ORGANS | 2002 |
|
RU2257895C2 |
| INHIBITORS - AMINO - CARBOXYMUCONATE - SEMIALDEHYDE - DECARBOXYLASE | 2015 |
|
RU2746405C2 |
| AGENT FOR TREATING ACUTE RENAL INJURY CAUSED BY CONTRAST AGENT | 2021 |
|
RU2817980C1 |
| FLAVONOID COMPOUNDS AND USE THEREOF | 2006 |
|
RU2431634C2 |
